Edition:
India

Amneal Pharmaceuticals Inc (AMRX.N)

AMRX.N on New York Stock Exchange

4.33USD
31 Jul 2020
Change (% chg)

$-0.03 (-0.69%)
Prev Close
$4.36
Open
$4.30
Day's High
$4.39
Day's Low
$4.28
Volume
238,265
Avg. Vol
359,377
52-wk High
$5.78
52-wk Low
$2.27

Select another date:

Fri, Jul 10 2020

BRIEF-Amneal Launches Generic Fluphenazine Following ANDA Approval By FDA

* AMNEAL LAUNCHES GENERIC FLUPHENAZINE FOLLOWING ANDA APPROVAL BY FDA

BRIEF-Amneal Reports Q1 Adjusted Earnings Per Share $0.20

* Q1 REVENUE $499 MILLION VERSUS REFINITIV IBES ESTIMATE OF $446.1 MILLION

BRIEF-Amneal Launches Generic Butrans Following ANDA Approval By FDA

* AMNEAL LAUNCHES GENERIC BUTRANS® FOLLOWING ANDA APPROVAL BY FDA Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

BRIEF-Amneal Accelerates Production Of Hydroxychloroquine Sulfate

* AMNEAL ACCELERATES DISTRIBUTION AND PRODUCTION OF HYDROXYCHLOROQUINE SULFATE TO MEET POTENTIAL NEEDS OF COVID-19 PATIENTS NATIONWIDE

BRIEF-Amneal Pharmaceuticals Appoints Tasos Konidaris As Senior Vice President, CFO

* AMNEAL PHARMACEUTICALS APPOINTS TASOS KONIDARIS AS SENIOR VICE PRESIDENT, CHIEF FINANCIAL OFFICER

Select another date: